Anne Kopp

Anti-complement-factor H-associated glomerulopathies

Be on Target: Strategies of Targeting Alternative and Lectin Pathway Components in Complement-Mediated Diseases

Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases

Inflammation and tumor progression: signaling pathways and targeted intervention

Neurotropic virus infections as the cause of immediate and delayed neuropathology

Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue

Diversity, Mechanisms, and Significance of Macrophage Plasticity

Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System?

PTX3, a Humoral Pattern Recognition Molecule, in Innate Immunity, Tissue Repair, and Cancer

Complement in removal of the dead – balancing inflammation

Factor H: A Complement Regulator in Health and Disease, and a Mediator of Cellular Interactions

Factor H–Related Protein 5 Interacts with Pentraxin 3 and the Extracellular Matrix and Modulates Complement Activation

Atypical Hemolytic Uremic Syndrome-Associated Variants and Autoantibodies Impair Binding of Factor H and Factor H-Related Protein 1 to Pentraxin 3

Provenance and Geographic Spread of St. Louis Encephalitis Virus